from raccoons do not efficiently bind the dog transferrin receptor (TfR) or infect dog cells, a 27 single mutation changing an aspartic acid to a glycine at capsid (VP2) position 300 in the 28 prototype raccoon CPV allows dog cell infection. As VP2 position 300 exhibits extensive amino 29 acid variation among the carnivore parvoviruses, we further investigated its role in determining 30 host range by analyzing its diversity and evolution in nature, and by creating a comprehensive 31 set of VP2 position 300 residues in infectious clones. Notably, some position 300 residues 32 rendered CPV non-infectious for dog, but not cat or fox, cells. Changes of adjacent residues 33 (299 and 301) were also often observed after cell culture passage in different hosts, and some 34 of those mimicked changes seen in viruses recovered from natural infections of alternative 35 hosts, suggesting that compensatory mutations were selected to accommodate the new 300 36 residue. Analysis of the TfRs of carnivore hosts used in the experimental evolution studies 37 demonstrated that their glycosylation patterns varied, including a glycan present only on the 38 domestic dog TfR that dictates parvovirus susceptibility. Overall, there were significant 39 differences in the ability of viruses with alternative 300 residues to bind TfRs and infect different 40 carnivore hosts, demonstrating that the process of infection is highly host-dependent and that 41 VP2 position 300 is a key determinant of host range. carnivores that is non-infectious to dogs, and that the ability of CPV to infect and spread 88 efficiently in the dog population was due to a limited number of amino acid substitutions in the 89 capsid (6, 7). These capsid mutations enabled the virus to bind efficiently to the transferrin type 90 1 receptor (TfR) on dog cells allowing for infection, and that change appears to be a key event 91 in the pandemic emergence of CPV (8-10). It was later demonstrated that a unique 92 glycosylation site found only in the TfR of dogs and very closely related canids (coyotes [Canis 93 latrans] and gray wolves [Canis lupus]) was a primary determinant blocking binding and 94 infection of FP-like viruses in these species, which was overcome by CPV (11-15). Since its 95 emergence, CPV has not only continued to circulate worldwide in domestic dogs and cats, but is 96 also endemic in sylvatic cycles among various wild carnivore species such as raccoons 97 (Procyon lotor), pumas (Puma concolor), fishers (Martes pennanti), coyotes, and wolves, which 98 in turn suggests that cross-species transmission events between domestic and non-domestic 99 carnivores has played a major role in CPV evolution (15-17).
100
The capsid of CPV is a non-enveloped T=1 icosahedron that is 26 nm in diameter and is 
MATERIALS AND METHODS

154
Evolution of VP2 amino acid residue 300 in nature. To determine the evolution of were then dialyzed overnight in PBS and concentrated using a 100-kD Amicon Ultra-15 271 centrifugal filter unit (Millipore). Protein concentrations were measured using a NanoDrop 272 spectrophotometer (ThermoScientific) and purity was assessed by SDS-PAGE. 
RESULTS
344
To examine the role of VP2 residues 299, 300 and/or 301 ( Fig. 1 Table 1 . Table 1) .
397
Additional mutations of residues that flank VP2 position 300 were also observed upon 398 passage of CPV in dog cells, but those occurred only at position 301 and, in some cases, these 399 were found to be consistently polymorphic. For example, passage of 300-Val in dog cells 400 resulted in a mutation from the consensus 301-Thr to a Pro (Fig. 2) (Fig. 4A ) and the induction of cytopathic effects (Fig. 4B) . Interestingly, the only virus 405 in which multiple different 301 mutations were detected was 300-Gly, which is the normal VP2 (Fig. 5) . 420 However, both the VP2 300-Asp and 300-Gly were quickly selected against in cat cells, 421 resulting in changes of Asp (GAT) to a His (CAT) and Gly (GGT) to Val (GTT) (Fig. 5) . (Fig. 5) , two changes that have been recognized as amino acid 438 differences between FPV and CPV (6, 7, 16).
439
As noted above, the introduction of either an Asp or Gly at position 300 in FPV resulted 440 in the selection of a His or Val, respectively, when passaged in NLFK cells ( Fig. 6A and C) . To 441 analyze the effects of these mutations, we compared the growth curves of these four viruses
442
(300-Asp versus 300-His and 300-Gly versus 300-Val) in cat cells. We also performed growth 443 curves with the FPV prototype, 300-Ala, as a control (not shown). When comparing 300-Asp to 444 its descendant virus, 300-His, both viruses reached their peak titers by day 5. However, the 445 peak titer of 300-His was >150-fold higher than that of the 300-Asp mutant (8.4 x 10 4 versus 1.2 446 x 10 7 TCID 50 /ml) (Fig. 6B) . Similarly, comparison of the 300-Gly versus 300-Val mutation 447 showed increases in fitness, with the 300-Val mutant having an approximate 18-fold higher peak 448 titer (7.0 x 10 5 versus 1.2 x 10 7 TCID 50 /ml) (Fig. 6D) . The peak titers of the FPV 300-His and (Man) 3 (GlcNAc) 2 , while one glycoform had a single deoxyhexose addition (Fig. S1) prototype CPV (300-Gly) (Fig. 9C) , confirming that the parvovirus binding site is not directly (Fig. 9D) , although the relative infectivity of FPV for 496 the Endo H-treated dog cells was substantially lower than seen for cat cells. Interestingly, Endo
497
H treatment of dog cells also resulted in a marked increase in CPV infection (Fig. 9D) , 498 suggesting that, although CPV gained the ability to infect dogs and their relatives (coyotes, many mutants in a CPV background were unable to infect domestic dog cells (Fig. 2 and 3) , but instead showed other changes at position 556 such as Gly or His (Fig. 2 and 7) , suggesting 540 that VP2 residues 300 and 556 are connected in forming the binding site to the gray fox TfR.
541
Selection of additional mutations in the capsid after changes to VP2 position 300.
542
Additional VP2 mutations that arose after cell culture passage were found to be in very close 543 proximity to the 300 loop region, suggesting that they were associated with optimal receptor 544 binding for infection. For instance, passage of the 300-Ala CPV mutant in dog cells resulted in 545 the mutation of VP2 position 565 from an Asp to a Lys (Fig. 7C) , which is directly adjacent to a 546 known host range mutation (VP2 564) that differs between FPV and CPV (7, 10-11). Molecular mutations. Indeed, we were able to show that position 301 mutations that arise after 570 introduction of a new 300 residue can greatly increase viral fitness (Fig. 4) . was a key step in its pandemic emergence (14). However, it also appears likely that this unique 606 fourth glycan present on the dog, coyote, and gray wolf TfR may also reduce CPV infectivity, as 607 its removal by glycosidase treatment also allowed increased infection of the prototype CPV 608 found in those species (CPV 300-Gly) (Fig. 9D) in one VP2 monomer (e.g., dark gray) is in close proximity to two other VP2 monomers, one from 771 the same three-fold spike (e.g., green) and one from a neighboring subunit (e.g., dark blue). shown, with the subdomains color-coded: apical (white), protease-like (grey), and helical (aqua).
865 TABLE 1. Natural variation observed at VP2 position 300 among the carnivore parvoviruses. All eight amino acid residues that are known to naturally occur are shown, along with the host(s) from which they have been recovered (and their taxonomic classification), the geographical distribution or specific location of isolation for each particular VP2 300 mutation, and representative GenBank accession numbers.
